KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.05
−18.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.79x
- Price / sales
- 9.27x
- Price / cash flow
- -6.41x
Enterprise value
- Enterprise value
- $221.6M
- EV / sales
- 2.87x
- EV / EBITDA
- -0.75x
- EV / EBIT
- -0.70x
- Market cap
- $716.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026